PRODUCT INFORMATION
Description
The F3 peptide, a proteolytic fragment derived from human high-mobility group protein B2 (HMGB2), demonstrates tumor-selective targeting capabilities. It binds with high affinity to membrane-associated nucleolin, which is expressed on cancer cells and angiogenic vascular endothelium. This molecular interaction enables its use as a multifunctional ligand for researching targeted molecular delivery systems in vitro and in vivo models.
Molecular Weight
3433.02
Purity
> 95%
Formula
C₁₅₂H₂₆₃N₄₉O₄₁
Product Type
Targeting Peptide
Sequence
Lys-Asp-Glu-Pro-Gln-Arg-Arg-Ser-Ala-Arg-Leu-Ser-Ala-Lys-Pro-Ala-Pro-Pro-Lys-Pro-Glu-Pro-Lys-Pro-Lys-Lys-Ala-Pro-Ala-Lys-Lys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- MH42 Targeting Peptide (CAT#: OLY-1025-YS-31)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.